Editor's Note Research reveals nearly 10% of patients treated with prescription opioid painkillers develop opioid dependency or opioid use disorder (OUD), Healio reported on August 13. Additionally, nearly 30% of patients exhibit signs and symptoms indicating potential OUD. Originally published in the journal Addiction, the data are from a systematic…

Read More

Editor's Note The Food and Drug Administration (FDA) approved Amneal Pharmaceuticals' Abbreviated New Drug Application for single-dose vials of propofol injectable emulsion, Anesthesiology News August 23 reports. The newly approved formulations include 200 mg/20 mL, 500 mg/50 mL, and 1,000 mg/100 mL vials. Propofol is widely used for anesthesia and…

Read More

Editor's Note Medicare’s first negotiations on 10 top-selling prescription drugs for older Americans will save the US government $6 billion in the first year, according to an August 15 article in Reuters. Enabled by President Joe Biden’s 2022 Inflation Reduction Act, negotiations for drugs used by Medicare—which covers 66 million…

Read More

Editor's Note In a new guidance document for manufacturers of pharmaceuticals and biopharmaceuticals, The Association for the Advancement of Medical Instrumentation (AAMI) has released a new guidance document updating best practices for radiation sterilization validation and routine control of single-use systems. The document, AAMI CR513:2024; Guidance on radiation sterilization validation and…

Read More

Editor's Note Erin Fox, senior pharmacy director at University of Utah Health who has been monitoring drug shortages for over 20 years, spoke to AP News in June of her concerns. Currently, the situation is worse than ever, with total active shortages hitting an all-time high of 323 (with 48…

Read More

Editor's Note Shortages of active drugs in the US have reached a new record, according to an April 12 CNN report on data from the American Society of Health-System Pharmacists and the University of Utah Drug Information Service. The two organizations have been tracking this data since 2001, the CNN report says.…

Read More

Editor's Note The US Food and Drug administration approved Zevtera for treating Staphylococcus aureus bacteremia (SAB) bloodstream infections, which are often acquired in healthcare settings. In the April 3 announcement, the agency notes the new antibiotic Zevtera (ceftobiprole medocaril sodium for injection) is effective for SAB-infected patients with right-sided infective…

Read More

Editor's Note The ransomware group behind a recent cyberattack on one of the nation’s largest health systems has its sights set on hospitals, the FBI and the Department of Health and Human Services (HHS) warned February 27. According to a report in Chief Healthcare Executive one day later, systems were…

Read More

Editor's Note:  The U.S. Justice Department is investigating how the healthcare industry is using artificial intelligence (AI) tools to analyze and make decisions using patients’ electronic health records (EHRs), Bloomberg Law reported January 29. So far, DOJ has served subpoenas related to EHRs to at least three major pharma companies:…

Read More

Editor's Note The US Food and Drug Administration (FDA) announced on July 6 that it would alter its emergency use authorization for the Paxlovid pill—Pfizer’s oral antiviral pill used by some to treat COVID-19—to allow pharmacists to prescribe the treatment to recently affected individuals directly. According to Fierce Pharma July…

Read More